We believe LibiGel could be first product to advertise for this unmet medical want.

BioSante Pharmaceuticals’ LibiGel clinical upgrade to be presented in 2010 ISSWSH annual meeting BioSante Pharmaceuticals, Inc. Petersburg, Florida. BioSante is in Stage III advancement of LibiGel for the treating hypoactive libido disorder in menopausal females under an FDA approved SPA . BioSante is enrolling women in three Stage III clinical research with a fresh drug application prepared for mid-2011. We believe LibiGel could be first product to advertise for this unmet medical want. Snabes.Targeting the biology and development properties of malignancy cells could broaden the repertoire of usable therapeutic brokers and offer better outcomes for individuals.’ Dr. Dick is famous for pioneering the tumor stem cell field by determining leukemia stem cells in 1994 and cancer of the colon stem cells in 2007. In 2011 Also, Dr. Dick isolated the standard human bloodstream stem cell in its purest type – as an individual stem cell with the capacity of regenerating the complete blood program. Collectively, Dr. Dick's research is paving just how for better clinical cancers therapy.. Aristada extended launch injection approved to treat adults with schizophrenia On 5 October, the U.S. Food and Drug Administration accepted Aristada prolonged release injection to take care of adults with schizophrenia.